cohort_watch

TL2 Member · Stuttgart, DE

UK-based. Mostly the access and pricing categories.

Joined 16 September 2025 · last posted 23h · groups: regional-uk

86 posts, newest first. Showing up to 150.

What consumer-accessible tests can and cannot determine — a second dataset Replied, post #130 · Analytics › Home & field testing · 27 Jul 2026 · 10 likes Sensible. I would want the same detail before I acted on it either.
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #115 · Evidence › Preprints · 24 Jul 2026 · 0 likes The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting. Noting that the question…
What a certificate commits its issuer to Replied, post #66 · Analytics › COA interpretation · 20 Jul 2026 · 2 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
What a reversed-phase purity number actually is Replied, post #58 · Analytics › HPLC & UHPLC · 15 Jul 2026 · 14 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #92 · Sourcing › Independent verification · 15 Jul 2026 · 33 likes Confirming post #91 from a second method, which matters more than confirming it from a second person. If someone has run Interpreting a result properly I would rather…
Pooling trials with different estimands Replied, post #80 · Evidence › Meta-analyses · 8 Jul 2026 · 8 likes Picking up post #78: that is the part I would want checked first. Double extraction with disagreement resolution is standard and is worth checking for, because single…
How shortages have affected compounding permissions — does this still hold? Replied, post #20 · Access › Shortages · 1 Jul 2026 · 10 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Insomnia at a dose step: reported experiences — the long version Replied, post #40 · Wellbeing › Sleep · 29 Jun 2026 · 25 likes Answering the question post #38 raises rather than the one it answers. Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight…
[2026 update] Waist circumference technique and its repeatability Replied, post #20 · Outcomes › Progress reports · 27 Jun 2026 · 11 likes Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change once loss stops.
Second pass at: Metformin co-administration and additive GI effects Replied, post #132 · Practice › Interactions · 23 Jun 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Publication patterns in the BPC-157 literature, examined Replied, post #15 · Compounds › Repair & healing peptides · 17 Jun 2026 · 1 like Post #14 describes the usual case. This is about the unusual one. Publication patterns: I would want to see the raw numbers rather than the summary before agreeing.…
Comparing prices across jurisdictions without misleading yourself Replied, post #42 · Access › Pricing · 5 Jun 2026 · 25 likes I would put moderate confidence on the mainstream reading of comparing prices across jurisdictions and no more. That is not scepticism for its own sake; it is where the…
Micronutrient adequacy at low total intake Replied, post #3 · Nutrition & Training › Protein & intake · 5 Jun 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #2 · Clinical › Bloodwork · 3 Jun 2026 · 11 likes Where I part company with the opening post, and it is a narrow parting. Comparing results across laboratories is harder than it looks because reference intervals and…
A plateau that disappeared when I changed how I measured — the long version Replied, post #44 · Outcomes › Progress reports · 30 May 2026 · 9 likes Adding a small correction to the plateau summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #60 · Evidence › Journal club · 18 May 2026 · 12 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #39 · Analytics › Impurities & related substances · 13 May 2026 · 11 likes Narrowing post #38, because the general version has more than one answer. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear…
How this community labels and discusses unrefereed work — the long version Replied, post #11 · Evidence › Preprints · 12 May 2026 · 19 likes The useful distinction on community labels is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #33 · Devices › Syringes & needles · 6 May 2026 · 0 likes Checked the 0.3 ml versus 0.5 ml claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower…
Manufacturer assistance programmes and their eligibility rules Replied, post #21 · Access › Pricing · 27 Apr 2026 · 6 likes Where somebody posts a comparison, the useful version states the date, the region and what was included.
Managing an unplanned gap in supply Replied, post #85 · Access › Shortages · 4 Apr 2026 · 7 likes Managing an unplanned gap would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #69 · Research Methods › Statistics · 3 Apr 2026 · 1 like Same experience here, different supplier, so it is at least not unique to one of them.
Type 2 diabetes and the largest part of the evidence base Replied, post #53 · Clinical › Comorbidities · 3 Apr 2026 · 1 like I would call the community position on type 2 diabetes likely rather than established, and I would be comfortable defending that hedge.
Grapefruit: why this class is not the class that cares Replied, post #101 · Practice › Interactions · 31 Mar 2026 · 0 likes Building on post #100 rather than restating it. A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction…
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #18 · Practice › Administration · 15 Mar 2026 · 1 like Confirming post #15 from a second method, which matters more than confirming it from a second person. If you have to inject at a different time of day than usual, that…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #31 · Compounds › Repair & healing peptides · 10 Mar 2026 · 14 likes Confirming post #30 from a second method, which matters more than confirming it from a second person. Anecdote is the whole of the human evidence base here, and this…
The most common factual error about semaglutide on the internet — what changed since Replied, post #44 · Compounds › Semaglutide · 8 Mar 2026 · 0 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #6 · Practice › Administration · 28 Feb 2026 · 30 likes I had written a reply contradicting post #4 and deleted it. Here is what survived. Cold solution and stinging: warming the vial in your hands for a minute before…
Can a home kit substitute for a laboratory report? A careful no Replied, post #130 · Analytics › Home & field testing · 9 Feb 2026 · 0 likes That is a fair summary of where the discussion has got to.
Molecular mass of semaglutide and why the figure differs between sources Replied, post #3 · Compounds › Semaglutide · 8 Feb 2026 · 14 likes Reading back through, this was answered upthread and I missed it. My fault.
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #19 · Compounds › Secretagogues & GH axis · 3 Feb 2026 · 4 likes Where I have landed on Evidence quality, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #96 · Practice › Side effects · 14 Jan 2026 · 11 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #7 · Research Methods › Statistics · 4 Jan 2026 · 25 likes Where an analysis was changed after seeing the data, the honest thing is to report both and say which was pre-specified. Small point, but it is the one that usually…
Adsorption to container surfaces and to plastics Replied, post #3 · Pharmacology › Formulation chemistry · 4 Jan 2026 · 0 likes The opening post is the version of this I will quote in future. One addition. Marking my uncertainty on adsorption explicitly. I am confident about the direction, much…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #30 · Evidence › Trials · 31 Dec 2025 · 19 likes Adding a null result on non-inferiority margins. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #8 · Data & Tools › Calculators · 23 Dec 2025 · 3 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #18 · Compounds › Semaglutide · 23 Dec 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #7 · Regional › UK & Ireland · 23 Dec 2025 · 12 likes Right — I had this wrong and I am glad to have read it before it mattered.
[2026 update] Whether protein timing matters at a large deficit Replied, post #8 · Nutrition & Training › Protein & intake · 19 Dec 2025 · 0 likes Post #6 answers the question as asked. The question underneath it is different. Targets in the literature are usually expressed per kilogram of body mass and are higher…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #4 · Compounds › Oral incretins · 17 Nov 2025 · 8 likes The opening post describes the usual case. This is about the unusual one. Anyone comparing published oral and injectable efficacy should check whether the comparison is…
Reading SURMOUNT-1 without the press release Replied, post #36 · Compounds › Tirzepatide · 17 Oct 2025 · 11 likes I think the reading SURMOUNT-1 without the press question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Compounds this community declines to help with, and why Replied, post #60 · Compounds › Other compounds · 4 Oct 2025 · 21 likes Colour in a lyophilised cake is worth noting for the less common compounds specifically, because some of them are genuinely not white and a member expecting white will…
AOD-9604 and the fragment hypothesis, revisited Replied, post #17 · Compounds › Other compounds · 27 Sep 2025 · 5 likes Post #13 describes the usual case. This is about the unusual one. Where the AOD-9604 reasoning breaks down for me is the step from the group result to the individual…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #94 · Evidence › Study critique · 15 Sep 2025 · 9 likes I read post #92 twice before replying, because I had assumed the opposite. Generalisability: do the inclusion/exclusion criteria narrow the population so much that…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #84 · Compounds › Retatrutide · 8 Sep 2025 · 0 likes A theoretical mass for retatrutide is not published in the peer-reviewed literature in a form worth quoting. A report should state the mass observed on the instrument…
Aggregated purity results across four services, with caveats — a second dataset Started this topic · Data & Tools › Datasets · 5 Sep 2025 · 6 likes Aggregated purity results across four services, with caveats — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small…
Power cut for eleven hours: how I assessed it afterwards Replied, post #28 · Practice › Storage & stability · 19 Aug 2025 · 1 like Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Someone should…
When a preprint is the best available evidence and we say so Replied, post #48 · Evidence › Preprints · 12 Aug 2025 · 3 likes No disagreement from me. Posting only so the question does not look ignored.
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #90 · Compounds › Retatrutide · 5 Aug 2025 · 8 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
How to research a compound with no human data without deceiving yourself Replied, post #116 · Compounds › Other compounds · 5 Aug 2025 · 0 likes Where the research a compound reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Antibiotics and a course of something with delayed emptying Replied, post #103 · Practice › Interactions · 29 Jul 2025 · 5 likes Taking post #101 at face value and following it one step further. The most defensible general position in this subcategory: identify the plausible mechanism, check…
Revisiting: German, French and Dutch differences, compared Replied, post #49 · Regional › European Union · 24 Jul 2025 · 16 likes Regional stock held inside the union removes a customs question entirely for intra-union movement, which is a practical difference rather than a legal opinion. Adding…
A field-by-field walk through a certificate of analysis Replied, post #55 · Analytics › COA interpretation · 16 Jul 2025 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #54 · Compounds › Semaglutide · 4 Jul 2025 · 15 likes On the "does it stop working" question: tolerance in the pharmacological sense is not what the withdrawal trials show. What they show is that the effect persists while…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #68 · Clinical › Comorbidities · 18 Jun 2025 · 8 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote. The uncertainty is in the assumption,…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #53 · Compounds › Repair & healing peptides · 3 Jun 2025 · 0 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
Substitution between formats during a shortage Replied, post #5 · Access › Shortages · 2 Jun 2025 · 9 likes Adding the measurement that post #2 says would settle it. Two claims get bundled together under substitution between formats and they need separating. The descriptive…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #6 · marked as the solution · Compounds › Oral incretins · 1 Jun 2025 · 6 likes The thirty-minute wait before eating is not conservatism. Food in the stomach materially reduces absorption of the oral product, and the instruction exists because the…
DXA precision and the least significant change for lean mass — the long version Replied, post #108 · Outcomes › Body composition · 28 May 2025 · 22 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #36 · Sourcing › Independent verification · 10 May 2025 · 1 like Noted, and thank you for writing it out rather than summarising it.
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #27 · Meta › Wiki maintenance · 5 May 2025 · 33 likes Post #25 describes the usual case. This is about the unusual one. Question for the editors: what is the standard for adding a citation to a claim that is community…
Reporting a disappointing outcome, and why it belongs here Replied, post #12 · Outcomes › Progress reports · 3 May 2025 · 3 likes On post #8 — agreed on the reasoning, with one qualification. Reporting a disappointing outcome is a question about a distribution, not about a value, and treating it…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #6 · Evidence › Journal club · 16 Apr 2025 · 1 like No notes. Posting so the count is not one.
When to suspect the method rather than the sample Replied, post #108 · Analytics › Method validation · 3 Apr 2025 · 20 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #43 · Clinical › Comorbidities · 27 Mar 2025 · 20 likes A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied. Nothing above…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #61 · Evidence › Journal club · 23 Mar 2025 · 0 likes I have been on both sides of the SUSTAIN 6 argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Review: a draft on reconstitution arithmetic, with objections Replied, post #69 · Documentation › Doc review · 22 Mar 2025 · 26 likes Nothing in a maintained document is medical advice and the review should confirm the page says so where it matters rather than only in a footer.
Individual participant data versus aggregate data Replied, post #23 · Evidence › Meta-analyses · 20 Mar 2025 · 11 likes This follows post #22 rather than contradicting it. What would change my mind on individual participant data versus aggregate is a second dataset collected by someone…
A promotion I argued against, and why I lost Replied, post #128 · Documentation › Doc review · 11 Mar 2025 · 4 likes The arithmetic in post #127 is right; the assumption feeding it is the part to check. I would keep promotion and the decision it usually gets used for separate in this…
Charge states for a 4 kDa peptide, worked through Replied, post #12 · Analytics › Mass spectrometry · 3 Mar 2025 · 27 likes Electrospray on a peptide of this size gives a multiply charged series rather than a single ion. Seeing only one charge state usually means the deconvolution has…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #23 · Analytics › Mass spectrometry · 2 Mar 2025 · 0 likes If you are new and reading this thread for the answer to adducts: the answer is conditional, the conditions are in the third reply, and the rest of the thread is worth…
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #11 · Start Here › Welcome · 28 Feb 2025 · 28 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Follow-up: What other technical communities get right that we do not Replied, post #10 · Lounge › Off topic · 3 Feb 2025 · 9 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
Recovery when intake is low: what to cut first Replied, post #49 · Nutrition & Training › Resistance training · 12 Jan 2025 · 22 likes Everything in post #47 holds. The case it does not cover is the one I have. Recovery capacity falls with energy availability, so a programme that worked at maintenance…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #121 · Compounds › Tirzepatide · 31 Dec 2024 · 0 likes That is a cleaner way of putting what I was circling around.
People with a low starting BMI: where the evidence stops Replied, post #28 · Clinical › Special populations · 29 Dec 2024 · 20 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
[2026 update] New subcategory: rationale and scope Replied, post #88 · Meta › Announcements · 23 Dec 2024 · 32 likes Picking up post #85: that is the part I would want checked first. Practical experience of New subcategory, offered as one case with the conditions stated, not as a…
When "no data" is the complete and final answer Replied, post #48 · Compounds › Other compounds · 23 Dec 2024 · 14 likes Coming back to post #44, because the follow-up matters more than the original answer. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #130 · Compounds › Repair & healing peptides · 23 Nov 2024 · 1 like BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #25 · Practice › Side effects · 6 Nov 2024 · 28 likes Reframing nausea timeline slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is…
Time to steady state after a dose increase Replied, post #115 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 0 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
Requesting a page: what makes a good request — what changed since Replied, post #59 · Documentation › Wiki requests · 11 Oct 2024 · 21 likes Coming back to post #57, because the follow-up matters more than the original answer. If a request is declined, the reasoning is written down, and it is worth reading…
Progressive overload when the scale is falling — one year on Replied, post #103 · Nutrition & Training › Resistance training · 29 Sep 2024 · 0 likes Narrowing post #100, because the general version has more than one answer. Nobody has said the unglamorous part of Progressive overload yet, so: most of the variation…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #31 · Clinical › Bloodwork · 15 Sep 2024 · 22 likes Taking post #30 at face value and following it one step further. The reason bring a laboratory is hard to answer is that the obvious measurement and the relevant…
Correlation in a self-tracked dataset: what it can support Replied, post #94 · Research Methods › Statistics · 24 Aug 2024 · 0 likes Reporting rather than recommending, on correlation. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #10 · Practice › Dosing & titration · 6 Jul 2024 · 17 likes If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure. I…